Table 3 Risk of getting an incorrect answer that participants are willing to accept according to type of evidence user and scenario
Types of user of evidence | Acceptable risk (%) | |||||||
|---|---|---|---|---|---|---|---|---|
Na | Median | p25 | p75 | p5 | p95 | Min | Max | |
All participants (n = 325) | ||||||||
All scenarios | 945 | 10 | 5 | 15 | 1 | 30 | 0 | 50 |
Clinical Treatment (Scenario 1) | 313 | 10 | 5 | 15 | 1 | 30 | 0 | 50 |
Public Health Intervention (Scenario 2) | 320 | 10 | 5 | 15 | 1 | 30 | 0 | 50 |
Clinical Prevention (Scenario 3) | 312 | 6.5 | 5 | 10.5 | 1 | 30 | 0 | 50 |
Guideline developers (n = 94) | ||||||||
All scenarios | 275 | 6 | 5 | 10 | 1 | 25 | 0 | 50 |
Clinical Treatment (Scenario 1) | 91 | 5 | 5 | 10 | 1 | 20 | 1 | 38 |
Public Health Intervention (Scenario 2) | 94 | 10 | 5 | 15 | 1 | 25 | 0 | 50 |
Clinical Prevention (Scenario 3) | 90 | 5 | 5 | 10 | 1 | 25 | 1 | 42 |
Decisionmakersb (n = 182) | ||||||||
All scenarios | 527 | 10 | 5 | 15 | 1 | 34 | 0 | 50 |
Clinical Treatment (Scenario 1) | 175 | 10 | 5 | 15 | 1 | 30 | 0 | 50 |
Public Health Intervention (Scenario 2) | 177 | 10 | 5 | 18 | 1 | 40 | 0 | 50 |
Clinical Prevention (Scenario 3) | 175 | 10 | 5 | 15 | 0 | 40 | 0 | 50 |
Guideline developers and decisionmakersb (n = 49) | ||||||||
All scenarios | 143 | 6 | 5 | 10 | 1 | 25 | 0 | 50 |
Clinical Treatment (Scenario 1) | 47 | 8 | 5 | 15 | 1 | 30 | 0 | 50 |
Public Health Intervention (Scenario 2) | 49 | 5 | 5 | 10 | 1 | 25 | 0 | 41 |
Clinical Prevention (Scenario 3) | 47 | 5 | 2 | 10 | 0 | 25 | 0 | 50 |